ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

STAR completes enrollment.

July 30, 2004

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000

NCI Pushing Ahead With Antismoking Campaign Involving Entire States, Physicians, Even Lawyers

March 27, 1987

In Brief: Florida Osteopaths Join Medical Examiners, Nullify State’s Law Supporting Laetrile

January 18, 1985

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992